Commentary · 24 Feb 2026
Conference abstract
Vaccination with heat-shock protein-‘chaperoned’ α-synuclein as a novel immunotherapeutic strategy against parkinson’s disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
α-synuclein (α-Syn) is an amyloid-forming protein whose aggregation is linked to Parkinsonâ??s disease (PD), a â??misfoldingâ?? neurodegenerative disorder. α- Syn α has also been found to play a critical role in the immune imbalance accompanying disease progression, a feature that has prompted research on the immunological role of α-Syn in PD as well as the search for an effective α-Syn-based immunotherapy. In this work, we investigated a novel approach that simultaneously exploits two important features of certain heat-shock proteins (HSPs): Their classical â??chaperoneâ?? activities and their recently discovered and diverse â??immunoactiveâ?? properties. In particular, we have characterized the immune response elicited by immunization of naïve C57BL/6 mice with α-Syn/HSP protein combination. Our results show specific differences in mice immunized with the α-Syn/ HSP complex when compared to controls, including their Treg (CD4+CD25+Foxp3+) and Teff (CD4+Foxp3-) cell contents, altered antigen specific response of isolated splenocytes, and different anti-α Syn antibody levels in blood. Moreover, the measured serum levels of IFN-α and IL-10 cytokines indicated a unique shift towards aTh2 immunomodulatory/immunoprotective phenotype in mice immunized with α Syn/HSP. Finally, we have tested the therapeutic potential of the α-Syn/HSP vaccine in a 1.methyl-4.phenyl-1,2,3,6-tetrahydropyridine (MPTP) PD mouse model, showing improvements of PD symptoms in treated mice, according to standard behavioral tests (e.g. limb stride variation, rearing). Overall, we propose the use of functional â??HSP-chaperoned amyloid/ aggregating proteinsâ?? generated with appropriate HSP-client protein combinations, such as the α-Syn/HSP complex used in this study, as a novel strategy for immune-based intervention against synucleinopathies and other amyloid or â??misfoldingâ?? neurodegenerative disorders.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Neurological Disorders.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeurological Disorders
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Cintia Roodveldt”
